STAT3 and neoplasm: In our present study, we utilized our tumor heterogeneity model to investigate the impact of shikonin and its derivative DMAS on various cellular mechanisms, including apoptosis induction, the regulation of mitogen-activated protein kinases (MAPKs) and signal transducer and activator of transcription 3 (STAT3), as well as DNA damage response.